Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

14 registered trials, newest registry update first. Showing only trials linked to UBT251.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
UBT251 Injection Phase II Study (Overweight or Obesity)
NCT07177469
UBT251Phase 2CompletedThe United Bio-Technology (Hengqin) Co., Ltd.205Oct 22, 2025Nov 5, 2026
UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study
NCT07163624
UBT251Phase 2CompletedThe United Bio-Technology (Hengqin) Co., Ltd.211Nov 21, 2025Nov 5, 2026
UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)
NCT07648225
UBT251Phase 3Active not recruitingThe United Bio-Technology (Hengqin) Co., Ltd.600Sep 29, 2027Nov 5, 2026
UBT251 Injection Phase II Clinical Study (CKD)
NCT07134335
UBT251Phase 2RecruitingThe United Bio-Technology (Hengqin) Co., Ltd.180Jul 11, 2030Nov 3, 2026
A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
NCT07145151
UBT251Phase 2RecruitingThe United Bio-Technology (Hengqin) Co., Ltd.156Jun 4, 2027Nov 3, 2026
UBT251 Injection Phase Ⅲ Study (OSA-NPAP)
NCT07767942
UBT251Phase 3Not yet recruitingThe United Bio-Technology (Hengqin) Co., Ltd.150Sep 2028Nov 3, 2026
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
NCT07668388
UBT251Phase 2RecruitingNovo Nordisk A/S300Oct 4, 2027Oct 7, 2026
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1)
NCT07659574
UBT251Phase 3RecruitingThe United Bio-Technology (Hengqin) Co., Ltd.360Sep 24, 2027Sep 15, 2026
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
NCT07653477
UBT251Phase 3RecruitingThe United Bio-Technology (Hengqin) Co., Ltd.956Feb 29, 2028Sep 14, 2026
UBT251 Injection Phase Ⅲ Study (OSA-PAP)
NCT07806851
UBT251Phase 3Not yet recruitingThe United Bio-Technology (Hengqin) Co., Ltd.150Mar 2029Sep 8, 2026
A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
NCT07710729
UBT251Phase 1RecruitingNovo Nordisk A/S40Apr 27, 2027Aug 25, 2026
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
NCT07785934
UBT251Phase 1RecruitingThe United Bio-Technology (Hengqin) Co., Ltd.48Dec 2026Aug 25, 2026
A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
NCT07710768
UBT251Phase 1RecruitingNovo Nordisk A/S44Apr 7, 2027Aug 18, 2026
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
NCT07395687
UBT251Phase 2RecruitingNovo Nordisk A/S333Jan 14, 2027Apr 21, 2026

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.